Podcast: Exclusive – Top Medical Device Lobbyist On User-Fee Talks, Biden And New Congress, Implementing MCIT Rule

The MDMA’s Mark Leahey talked with Medtech Insight about how the medical device industry responded to the COVID-19 pandemic, plans for working with a new administration and Congress, and hopes for the MDUFA negotiations.

Medtech podcast
• Source: Citeline/Shutterstock

Mark Leahey, CEO of the Medical Device Manufacturers Association, sat down with Medtech Insight to talk about how the industry has tackled the coronavirus pandemic, and how the MDMA plans to lobby the new Biden White House and Congress, and negotiate with the US Food and Drug Administration on the new Medical Device User Fee Amendments (MDUFA) deal.

Listen to our podcast below:

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation